Invasive Hemodynamic Assessment of Patients with Heart Failure and Pulmonary Hypertension

被引：5

作者：

Patil R.K. ^{[1
]}

Goyal P. ^{[1
]}

Swaminathan R.V. ^{[2
]}

Kim L.K. ^{[1
]}

Feldman D.N. ^{[1
]}

机构：

[1] Weill Cornell Medical College, Division of Cardiology, New York Presbyterian Hospital, 520 East 70th Street, New York, 10021, NY

[2] Duke Clinical Research Institute, Duke University Medical Center, Durham, 27705, NC

来源：

Current Treatment Options in Cardiovascular Medicine | 2017年 / 19卷 / 6期

关键词：

Exercise hemodynamics; Heart failure; Heart failure with preserved ejection fraction; Implantable hemodynamic monitor; Pulmonary hypertension; Right heart catheterization;

D O I：

10.1007/s11936-017-0544-4

中图分类号：

学科分类号：

摘要：

Right heart catheterization (RHC) with a pulmonary artery (PA) catheter is a minimally invasive method of obtaining hemodynamic data (e.g., right atrial and pulmonary pressures, cardiac output, pulmonary vascular resistance), which are used to diagnose and manage patients with advanced heart failure (HF), HF with preserved ejection fraction, and pulmonary hypertension (PH). Invasive hemodynamic data obtained from RHC can aid in the prognostication of HF and PH patients and are important in guiding decisions of implanting mechanical circulatory support devices and listing patients for heart and/or lung transplantation. The basis of RHC has also paved the way for implantable hemodynamic devices to monitor pulmonary artery pressures in the outpatient setting, which can reduce rates of HF-related hospitalizations. We will discuss the utility of PA catheters in the diagnosis and management of the aforementioned disease states, the role of implantable hemodynamic monitors, and the complications associated with RHC procedures. © 2017, Springer Science+Business Media New York.

引用

共 65 条

[1]

Nossaman B.D., Scruggs B.A., Nossaman V.E., Et al., History of right heart catheterization: 100 years of experimentation and methodology development, Cardiol Rev, 18, 2, pp. 94-101, (2010)

[2]

Cournand A., Cardiac catheterization

[3]

development of the technique, its contributions to experimental medicine, and its initial applications in man, Acta Med Scand Suppl, 579, pp. 3-32, (1975)

[4]

Ems F., Heart catheterization, JAMA, 162, 16, (1956)

[5]

Gidwani U., Mohanty B., Chatterjee K., The pulmonary artery catheter: a critical reappraisal, Cardiol Clin, 31, 4, pp. 545-565, (2013)

[6]

Bernard G.R., Sopko G., Cerra F., Et al., Pulmonary artery catheterization and clinical outcomes: National Heart, Lung, and Blood Institute and Food and Drug Administration workshop report, Consensus Statement JAMA, 283, 19, pp. 2568-2572, (2000)

[7]

Wiener R.S., Welch G., Trends in the use of the pulmonary artery catheter in the United States, 1993-2004, JAMA, 298, 4, pp. 423-429, (2007)

[8]

De Backer D., Is there a role for invasive hemodynamic monitoring in acute heart failure management?, Curr Heart Fail Rep, 12, 3, pp. 197-204, (2015)

[9]

Connors A.F., Speroff T., Dawson N.V., Et al., The effectiveness of right heart catheterization in the initial care of critically ill patients: SUPPORT investigators, JAMA, 276, 11, pp. 889-897, (1996)

[10]

Binanay C., Califf R.M., Hasselblad V., Et al., Evaluation study of Congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial, JAMA, 294, 13, pp. 1625-1633, (2005)

← 1 2 3 4 5 6 7 →